While more than half of the 2,000 US adults who responded to [removed]an online survey reported [/removed]experiencing sleep issues due to their nasal allergy symptoms, only 35% proactively treat their symptoms. Almost half (48%) the respondents said their nasal allergy symptoms also interrupted their partner’s sleep.

“This survey further reinforces that although many people are significantly impacted by their nasal allergies, they are doing very little to avoid the onset of their burdensome symptoms,” said Bill McLin, president and CEO of AAFA. “As such, we are thrilled to continue our partnership with Misty and Teva Respiratory on the Ditch the Drip program to help provide people with nasal allergies with tools and resources they can use to better prepare for peak allergy seasons and nip their symptoms in the bud.”

Ditch the Drip, with spokesperson Misty May-Treanor, hopes to elevate the seriousness of nasal allergies and educate the 60 million Americans suffering from nasal allergies about the need for proactive preparation in advance of peak allergy seasons.

The survey, conducted by Manhattan Research on behalf of Teva Respiratory, also found that 69% of respondents use two or more medications to treat their nasal allergies, but only 31% treat them before symptoms appear. Additional findings: 57% experienced difficulty concentrating at work and 61% said they cannot enjoy the outdoors with their children as much as they would like due to their nasal allergies.